maximizing Oncology investigate with Integrated KRAS Assay products and services and RAS Assays
inside the fast evolving discipline of oncology research, correct and economical mutation screening is vital for creating specific therapies. The KRAS expert services Platform plays a pivotal part On this landscape by giving extensive methods for KRAS mutation profiling and analysis. KRAS mutations, present in about 95% of RAS-associated oncogenic